0 items USD 0.00Search
Your search for "current partnering multiple sclerosis partnering 2010 2015" gave back 643051 results.
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Multiple standard wavelength laser epilators are hair removal laser machines that are exposed to laser pulses that damage hair follicles. They remove...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Multiple standard wavelength laser Removal Machines market size was valued at US$ million in 2023. With growing demand in downstream...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Multiple Sclerosis Drugs market size was valued at US$ 14290 million in 2023. With growing demand in downstream market, the Multiple...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Multiple Sclerosis (MS) Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Multiple...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Multiple Sclerosis (MS) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Highlights The global Relapsing Multiple Sclerosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Multiple Sclerosis Therapies Market The global Multiple Sclerosis Therapies market is projected to grow from US...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Relapsing Multiple Sclerosis Treatment Market The global Relapsing Multiple Sclerosis Treatment market is...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
